Experimental and Therapeutic Medicine

简称 EXP THER MED ·GREECE ·年均收录 1056 篇

2.3

最新影响因子

4.20%

自引率

约75%

投稿难度

平均1.3月

审稿周期

期刊简介

Experimental and Therapeutic Medicine是一本国际医学期刊，ISSN号为1792-0981，由希腊出版商Spandidos Publications出版，出版地为希腊雅典，出版周期为月刊。该杂志的影响因子根据年份有所不同，近年约为2.0左右，是一本开放获取（OA）期刊，被SCI收录，在中科院分区中通常位于医学领域的3区或4区。杂志的发文特点涵盖广泛的实验医学和临床治疗研究，重点领域包括分子医学、药理学、病理学、免疫学及相关交叉学科，尤其欢迎转化医学和新型治疗方法的原创研究。杂志的质量中等，审稿速度较快，但由于开放获取模式及相对宽松的接收标准，可能存在一定学术风险，需注意文章质量的筛选。总体而言，该杂志适合需要快速发表且研究内容符合其范围的学者，但投稿前建议仔细评估其学术声誉和领域匹配度。

影响因子趋势

近期发表

Development of a recombinase‑aided amplification assay for rapid and sensitive detection of Pneumocystis jirovecii infection: A single‑center molecular study 2026-09-16

Effects of ketamine and dexmedetomidine on ischemia‑ reperfusion injury in an experimental renal ischemia model 2026-09-16

Severe steroid‑refractory immune checkpoint inhibitor‑associated pneumonitis and exploration of potential biomarkers: A case report 2026-09-16

[Corrigendum] Ginsenoside Rg1 ameliorates apoptosis, senescence and oxidative stress in ox‑LDL‑induced vascular endothelial cells via the AMPK/SIRT3/p53 signaling pathway 2026-09-16

Carrageenan‑induced immunothrombotic models in rodents (Review) 2026-09-16

BBS10 ‑related Bardet‑Biedl syndrome with an atypical presentation of diabetes mellitus: A case report 2026-09-16

[Retracted] Role of peptidylarginine deiminase type 4 in gastric cancer 2026-09-15

Immune checkpoint inhibitor‑induced myocarditis with myositis and/or myasthenia gravis overlap syndrome: A case series 2026-09-14

Cardiovascular health metrics and the risk of metabolic dysfunction‑associated steatosis liver disease: A meta‑analysis 2026-09-14

Reversible osimertinib‑associated heart failure mimicking cancer recurrence in EGFR ‑mutated non‑small cell lung cancer after pneumonectomy: A case report 2026-09-11